Dual Gip Glp 1 Receptor Agonist (disambiguation)

• GLP-1 Receptor Agonists

  Also: GLP-1 agonists, Incretin mimetics, GLP-1 analogues

  GLP-1 Receptor Agonists (Glucagon-Like Peptide-1 Receptor Agonists, sometimes shortened to GLP-1 RAs or incretin mimetics) are a class of injectable and oral medications that mimic…

• Semaglutide and tirzepatide

  Also: Ozempic, Rybelsus, Wegovy (semaglutide brands), Mounjaro, Zepbound (tirzepatide brands), GLP-1 receptor agonist (semaglutide's drug class)

  Semaglutide and tirzepatide are the two medicines that define the modern era of incretin-based therapy for type 2 diabetes and obesity. Semaglutide, developed by Novo…

• Obesity Medicine Association

  Also: OMA, American Society of Bariatric Physicians (former name), ASBP (former acronym)

  The Obesity Medicine Association (OMA) is the largest professional organization of clinicians in the United States and internationally dedicated to the comprehensive, evidence-based medical treatment…

• SURPASS Clinical Trials

  Also: SURPASS Clinical Development Program, Tirzepatide Type 2 Diabetes Trials, SURPASS Phase 3 Trials

  The SURPASS clinical trials comprise a landmark global Phase 3 clinical development program sponsored by Eli Lilly and Company to evaluate the efficacy, safety, and…

• Pancreatitis

  Also: Pancreatic Inflammation, Inflamed Pancreas, Acute Pancreatic Syndrome

  Pancreatitis is a pathological condition characterized by the inflammation of the pancreas, a vital glandular organ located behind the stomach that secretes digestive enzymes and…

• Metabolic Dysfunction-Associated Steatotic Liver Disease

  Also: MASLD, Non-Alcoholic Fatty Liver Disease (NAFLD, historical terminology), Metabolic hepatopathy

  Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD), is a clinical condition characterized by the accumulation of excess fat…

• Type 2 Diabetes Mellitus

  Also: T2DM, Type 2 diabetes, Non-insulin-dependent diabetes mellitus (NIDDM, historical)

  Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by hyperglycemia resulting from insulin resistance and progressive decline in pancreatic beta-cell insulin secretion.…

• Satiety Regulation

  Also: Appetite regulation, Satiety control, Hunger-satiety feedback system

  Satiety Regulation is the complex physiological process by which the body controls the sensation of fullness, appetite, and energy intake. This regulation is coordinated by…

• Insulin Resistance

  Also: Metabolic insensitivity to insulin, Impaired insulin sensitivity, Syndrome X (historical term for the associated metabolic cluster)

  Insulin Resistance is a pathological condition in which the body's cells — primarily in skeletal muscle, adipose tissue, and the liver — respond inadequately to…

• Gastric Emptying

  Also: Stomach emptying, Gastric motility, Gastrointestinal transit (specifically gastric phase)

  Gastric Emptying is the physiological process by which the contents of the stomach are moved into the duodenum of the small intestine for further digestion…

• Gastric Inhibitory Polypeptide

  Also: GIP, Glucose-dependent insulinotropic polypeptide, Glucose-dependent insulinotropic peptide

  Gastric Inhibitory Polypeptide (also known as glucose-dependent insulinotropic polypeptide or GIP) is a 42-amino-acid peptide hormone synthesized and secreted by the enteroendocrine K-cells located in…

• Incretin Hormones

  Also: Incretins, Gut hormones, Enterogastrones (historical classification)

  Incretin Hormones are a group of metabolic hormones released by the endocrine cells of the gastrointestinal tract in response to nutrient ingestion. They play a…

• Zepbound

  Also: Tirzepatide (generic name), Mounjaro (brand name for Type 2 Diabetes), LY3298176 (developmental code)

  Zepbound is the brand name for tirzepatide, a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, developed and manufactured by Eli…

• Retatrutide

  Also: LY3437943, GIP/GLP-1/Glucagon Triple Agonist, GGG Tri-Agonist

  Retatrutide is an investigational synthetic peptide that acts as a triple receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG)…

• Tirzepatide

  Also: Tirzepatide (generic / INN), Mounjaro (brand for Type 2 diabetes), Zepbound (brand for chronic weight management)

  Tirzepatide is a synthetic 39-amino-acid peptide medication developed by Eli Lilly and Company that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1…

• Mounjaro

  Also: Tirzepatide (generic name), Zepbound (brand name for weight management in the US), GIP/GLP-1 dual agonist

  Mounjaro (generic name: tirzepatide) is a prescription-only injectable medication developed by Eli Lilly and Company, indicated for the treatment of Type 2 diabetes mellitus and…

← Back to Wiki Philippines